Pfizer Inc



    Today's change

    0.03 / +0.10%

    1 year change


    As of Feb 05 2016 21:02 GMT. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. February 4, 2016

    Numbers games and existential angst

    Two down-at-heel figures loitered in a desolate landscape. It could have been Waiting for Godot, a play by Irish...

  2. Fast FT

    February 4, 2016

    AstraZeneca shares hit as 2016 revenue forecast to fall

    AstraZeneca’s chief executive Pascal Soriot may be reassured that the UK drugmaker is on the right path but...

Special Reports

  1. Corporate Longevity

    The FT launches a global investigation into the mixture of innovation and focus that c...
  2. Innovation in Healthcare

    Health systems around the world face rising demand from an ageing population. More eff...
Search more Special Reports on this topic.

  1. Fast FT

    February 4, 2016

    Opening Quote: Shell protects divi, Compass ploughs on

    Shell’s profits have slumped with the oil price, AstraZeneca’s sales are stalling, the Bank of England is set to hold...

  2. Fast FT

    February 4, 2016

    AstraZeneca warns of revenue, earnings drop this year

    AstraZeneca has cautioned shareholders that revenue and earnings per share this year will decline by a “low to mid...

  3. February 2, 2016

    Energy and bank stocks lead the market down

    US energy stocks took a beating on Tuesday after the price of crude oil tumbled amid growing concerns about cooling...

  4. February 2, 2016

    Pfizer insists US politicians will not scupper Allergan deal

    Drugmaker Pfizer has insisted that its $160bn takeover of Allergan will not be thwarted by political opposition, amid...

  5. Fast FT

    February 2, 2016

    Axovant plunges on Pfizer Alzheimer drug move

    Shares in Axovant, a small biotech pursuing the first approval for a new Alzheimer’s drug in over a decade, plunged 29...

  6. February 1, 2016

    Investor calls for big pharma to slim down grow louder

    Some of the world’s biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour...

  7. January 26, 2016

    England backs biosimilar challenger to Merck blockbuster

    England’s drugs cost watchdog has backed the use of cheaper copycat versions of one of the world’s best-selling...

  8. January 21, 2016

    Pascal Soriot confident of AstraZeneca’s independent course

    AstraZeneca would not have made as much progress in developing new cancer drugs had it been taken over by Pfizer,...

  9. January 21, 2016

    Drugmakers call for collective action on superbugs

    Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

  10. January 18, 2016

    Pharma sell-off threatens to stifle appetite for IPOs

    After months of battling a public outcry over high drug prices, the pharmaceuticals and biotech industry had hoped that...

  11. Fast FT

    January 14, 2016

    JPMorgan sees fewer mega-deals this year

    After a record year for M&A, JPMorgan Chase said on Thursday it expects fewer mega-deals in 2016. Chief financial...

  12. January 6, 2016

    The stateless company plays a risky game

    In 1909 Edward Hall, a vice-president of the American Telephone and Telegraph Company, lamented in a speech that: “The...

  13. January 4, 2016

    A strange aversion to corporate tax

    To tax and to please, no more than to love and be wise, is not given to men,” said the great Whig statesman, Edmund...

  14. January 3, 2016

    GSK and AstraZeneca prescribe different treatments

    For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical...

  15. December 21, 2015

    Dealmakers claim 2015 boom is different

    After a record-shattering year for global dealmaking, there is more to come.  That is the overwhelming message from top...

  16. December 18, 2015

    Generics revive Philippines pharma industry

    The Philippines is a developing country in which nearly 70 per cent of healthcare spending goes to the private sector....

  17. December 17, 2015

    BoE’s Carney plays the game of two halves

    Many Britons will be surprised to learn Mark Carney could stay on as the governor of the Bank of England. They never...

  18. Fast FT

    December 17, 2015

    Opening Quote - Peppa in pink with Spielberg deal

    Peppa Pig owner Entertainment One has made a deal with ET’s Steven Spielberg, AstraZeneca has revealed it will pay $4bn...

  19. December 16, 2015

    AstraZeneca pours millions into China R&D

    AstraZeneca is to invest hundreds of millions of dollars expanding its capacity to develop and manufacture drugs in...

  20. December 15, 2015

    FDA performs U-turn over restriction of pain drug

    US regulators have taken the rare step of reversing a decision aimed at curbing the use of a pain medicine after the...

  21. December 14, 2015

    AstraZeneca: in search of a blockbuster

    Jimmy Carter can tell you why AstraZeneca is contemplating paying $5bn for an unquoted Dutch biotech company with a...

  22. December 13, 2015

    Tax efficiency alone is no reason to do a deal

    Eric Schmidt, Google’s chairman, drew fire in 2013 when he defended the internet group’s tax affairs by pointing out...

  23. December 7, 2015

    Hillary Clinton plans ‘exit tax’ to tackle inversions

    Hillary Clinton is proposing to deter tax-cutting deals such as Pfizer’s planned $160bn takeover of Allergan by...

  24. December 3, 2015

    Pfizer to cut 120 jobs with closure of Cambridge R&D centre

    Pfizer is planning to close a research and development facility in Cambridge with the loss of up to 120 jobs, weakening...

  25. December 2, 2015

    M&As are under close scrutiny, and rightly so

    For most chief executives and chairmen, announcing a big deal can mean entering a world of pain. Even for those running...

  26. December 1, 2015

    The fine line between tax evasion and avoidance

    Ian Read, the irascible Scottish-born chief executive of Pfizer, must often have left his public relations advisers...

  27. November 27, 2015

    Pfizer’s Ian Read looks to count Allergan merger as his legacy

    For Ian Read, Pfizer’s $160bn tie-up with Allergan announced this week marked the end of a two-year search for a...

  28. November 26, 2015

    Ireland should beware a return to boom and bust

    Of all the countries afflicted by the global financial crisis, few have rebounded more remarkably than Ireland. After...

  29. November 25, 2015

    Big Pharma has become addicted to an illusion

    Pharmaceuticals companies used to be research enterprises that discovered and developed drugs. Then they became...

  30. November 24, 2015

    Political risk clouds Pfizer-Allergan deal

    Pfizer and Allergan would have to pay the other party just $400m if either one pulled out of their $160bn deal due to a...

  31. November 24, 2015

    Corporate tax: The $240bn black hole

    An ageing industrial estate in the working-class Dublin suburb of Clonshaugh is an unexpected place to find evidence of...

  32. November 24, 2015

    Obama should close Pfizer’s tax loophole

    America’s pharmaceutical companies sometimes seem to be on a one-sector mission to alienate the entire US public. After...

  33. November 24, 2015

    Ireland: bank on it

    Ireland is more than a low corporate tax rate, though Pfizer — which has bought a $160bn ticket to Dublin by buying...

  34. FT Alphaville

    November 24, 2015

    FT Opening Quote - Rolls-Royce restructures

    Warren East is trying to prevent Rolls-Royce going west with his restructuring plan, Pfizer is under fire for its tax...

  35. November 23, 2015

    Pfizer seeks Washington support for $160bn Allergan deal

    Pfizer’s chief executive has called on Washington to support its $160bn takeover of Dublin-based Allergan, as...

  36. November 23, 2015

    Digital downloads weigh on GameStop

    GameStop was the biggest decliner on the S&P 500 at one stage on Monday after the US video game retailer reported...

  37. November 23, 2015

    Pfizer / Allergan: history will not repeat

    A little context, to start. In 2009, Pfizer paid $68bn to buy Wyeth. The buyer had revenues of $48bn; the target,...

  38. November 23, 2015

    Pfizer looks to bulk up in era of slimming down

    When Pfizer revealed its most recent mega-merger, the $68bn takeover of Wyeth in 2009, Jeffrey Kindler, then chief...

Search for Pfizer Inc and